A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Schones, Dustin E., Ph.D. Laboratory Bookmark and Share

Laboratory of Dustin E. Schones, Ph.D.

Our lab is generally interested in the role of chromatin in gene regulation and how other regulatory elements interact with chromatin. In addition to this, we are interested in how genetic variation interacts with epigenetic variation in the development of diseases such as diabetes and cancer. We utilize an integrative approach, combining experimental and computational methods, to study these problems.
 
One area of the lab is focused on the basic biology of mechanisms responsible for regulating chromatin architecture. We have identified characteristic chromatin patterns at functional regulatory regions of the genome, including promoter and distal enhancer regions. We are furthermore tracking changes in nucleosome positions along various lineage commitment pathways and investigating what mechanisms are responsible for regulating chromatin changes as well as how the changes in chromatin influence other regulatory events.
 
In addition, we are exploring the interaction of epigenetic and genetic variation in mouse models of cancer and diabetes. Genome-wide profiles of chromatin modifications, transcription factor binding, transcript production and genetic variation all provide one-dimensional views of genome regulation. To truly understand the regulatory networks involved in normal development – and how these networks are disrupted in disease progression – we must begin to integrate these data sets. Our results indicate that changes in chromatin accessibility cooperate with genetic variation to influence phenotypes. We are developing methods to integrate genotype, gene expression and chromatin information in prediction of phenotype. Furthermore, we are using these data from model systems to evaluate the potential of obtaining relevant genotype information from chromatin accessibility profiling. We anticipate these methods will be of practical use for personalized medicine in the clinic.
 
 
For more information on Dr. Schones, please click here.

Dustin Schones, Ph.D. Lab Members

Lab Members:
 
Beisi Xu, Ph.D.
Postdoctoral Fellow
626-256-4673, ext. 63300
beixu@coh.org
 
Juan Du
Grad Student
626-256-4673 ext. 64521
jdu@coh.org
 
Candi Trac, M.S.
Research Associate II
626-256-4673, ext. 64521
ctrac@coh.org

Schones, Dustin E., Ph.D. Laboratory

Laboratory of Dustin E. Schones, Ph.D.

Our lab is generally interested in the role of chromatin in gene regulation and how other regulatory elements interact with chromatin. In addition to this, we are interested in how genetic variation interacts with epigenetic variation in the development of diseases such as diabetes and cancer. We utilize an integrative approach, combining experimental and computational methods, to study these problems.
 
One area of the lab is focused on the basic biology of mechanisms responsible for regulating chromatin architecture. We have identified characteristic chromatin patterns at functional regulatory regions of the genome, including promoter and distal enhancer regions. We are furthermore tracking changes in nucleosome positions along various lineage commitment pathways and investigating what mechanisms are responsible for regulating chromatin changes as well as how the changes in chromatin influence other regulatory events.
 
In addition, we are exploring the interaction of epigenetic and genetic variation in mouse models of cancer and diabetes. Genome-wide profiles of chromatin modifications, transcription factor binding, transcript production and genetic variation all provide one-dimensional views of genome regulation. To truly understand the regulatory networks involved in normal development – and how these networks are disrupted in disease progression – we must begin to integrate these data sets. Our results indicate that changes in chromatin accessibility cooperate with genetic variation to influence phenotypes. We are developing methods to integrate genotype, gene expression and chromatin information in prediction of phenotype. Furthermore, we are using these data from model systems to evaluate the potential of obtaining relevant genotype information from chromatin accessibility profiling. We anticipate these methods will be of practical use for personalized medicine in the clinic.
 
 
For more information on Dr. Schones, please click here.

Lab Members

Dustin Schones, Ph.D. Lab Members

Lab Members:
 
Beisi Xu, Ph.D.
Postdoctoral Fellow
626-256-4673, ext. 63300
beixu@coh.org
 
Juan Du
Grad Student
626-256-4673 ext. 64521
jdu@coh.org
 
Candi Trac, M.S.
Research Associate II
626-256-4673, ext. 64521
ctrac@coh.org
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.

Learn more about
City of Hope's institutional distinctions, breakthrough innovations and collaborations.
 
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • Brain cancer may be one of the most-frightening diagnoses people can receive, striking at the very center of who we are as individuals. Further, it often develops over time, causing no symptoms until it’s already advanced. Listen to City of Hope Radio as Behnam Badie, M.D., director of the Brain Tumor Pro...
  • The whole is greater than the sum of its parts. It takes a village. No man is an island. Choose your aphorism: It’s a simple truth that collaboration usually is better than isolation. That’s especially true when you’re trying to introduce healthful habits and deliver health care to people at risk of disease and...
  • When Maryland Governor Larry Hogan announced earlier this week that he has the most common form of non-Hodgkin lymphoma, he was giving voice to the experience of more than 71,000 Americans each year. The announcement came with Hogan’s promise to stay in office while undergoing aggressive treatment for the...
  • The spine can be affected by many different kinds of tumors. Malignant, or cancerous, tumors can arise within the spine itself. Secondary spinal tumors, which are actually much more common, begin as cancers in another part of the body, such as the breast and prostate, and then spread, or metastasize, to the spi...
  • Although most cancer occurs in older adults, the bulk of cancer research doesn’t focus on this vulnerable and fast-growing population. City of Hope and its Cancer and Aging Research Team aim to change that, and they’re getting a significant boost from Professional Practice Leader Peggy Burhenn, R.N....
  • Liz Graef-Larcher’s first brain tumor was discovered by accident six years ago. The then-48-year-old with a long history of sinus problems and headaches had been sent for an MRI, and the scan found a lesion in her brain called a meningioma – a tumor that arises in the meninges, the layers of tissue that cover a...
  • The colon and rectum are parts of the body’s gastrointestinal system, also called the digestive tract. After food is digested in the stomach and nutrients are absorbed in the small intestine, the remaining material moves down into the lower large intestine (colon) where water and nutrients are absorbed. The low...
  • If there is one truism about hospital stays it is that patients want to get out. For many, however, the joy of being discharged is tempered by the unexpected challenges that recovery in a new setting may pose. Even with professional help, the quality of care and treatment that patients receive at City of Hope [...
  • Jana Portnow, M.D., associate director of the Brain Tumor Program at City of Hope, didn’t expect to specialize in treating brain tumors. But, early in her career, she undertook a year of research on pain management and palliative care and, in that program, got to know many patients with brain tumors. After that...
  • Ask any patient: Nurses are as pivotal in their care as doctors. They answer the call of a patient in the middle of the night, they hold the patient’s hand as he or she takes on yet another round of treatment and, in the best-case scenario, they wave goodbye as the patient leaves the hospital, […]
  • Many oncologists, not to mention their patients, might think that there’s no place for mathematical analysis in the treatment of cancer. They might think that all treatment decisions are based on unique factors affecting individual patients, with no connection to other patients and their treatment regimen...
  • Within three days in 2007, Stephanie Hosford, then 37, learned that she was pregnant with her long-awaited second child – and that she had triple-negative breast cancer. Soon afterward, Hosford discovered that she and her husband, Grant, had been approved to adopt a little girl from China.  After encountering m...
  • That’s not an echo you hear, it’s another study linking weight to breast cancer risk. It’s also another reason to improve the health of our overall community. In a report published online June 11 in the journal JAMA Oncology, researchers have concluded that women who are both obese and postmenopausal face...
  • Cancer and other life-threatening illnesses can be overwhelming experiences for adults. For children, who lack the life experience and context to put their diagnosis in perspective, the treatment and follow-up can be especially isolating. City of Hope’s youngest patients recently got a chance to overcome that i...
  • When explaining breast cancer treatment options, breast cancer specialists typically discuss the best therapies currently available, working with their patients to create the most effective treatment regimens. Recently, however, City of Hope specialists – in oncology, surgery and immunology – came together to d...